Chondrometrics and Boston Imaging Core Lab (BICL) have formed a partnership to broaden and advance their capabilities for offering imaging biomarker analysis to osteoarthritis researchers in academia and pharmaceutical industry.
Dr. Guermazi, president, BICL, said: We are excited about this partnership and look forward to extending our already strong research collaboration into a closer strategic co-operation between the two companies.
Dr. Eckstein, CEO of Chondrometrics, said: This will allow us to offer the full spectrum of osteoarthritis imaging biomarkers, both quantitative and semi-quantitative, which recent research has been proven to provide complimentary and synergistic rather than competing or overlapping information in clinical trials.
Chondrometrics is a provider of software-based quantitative medical image analysis, with a focus on articular cartilage and other joint structures in osteoarthritis.
BICL is a provider of semi-quantitative radiological reading services, which are based on advanced radiological scoring systems, including all relevant joint tissues affected by osteoarthritis.